Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Guest Editorial
Geriatric Psychiatry: A Subspecialty Whose Time Has Come

Nathan Herrmann

(PDF)


Special Geriatric Psychiatry Section
Canadian Outcomes Study in Dementia: Study Methods and Patient Characteristics

Robert Sambrook, Nathan Herrmann, Réjean Hébert, Peter McCracken, Alain Robillard, Doanh Luong, Amanda Yu

(PDF)

Exploring the Links Between Depression, Integrity, and Hope in the Elderly
William T Chimich, Cheryl L Nekolaichuk

(PDF)

Driving and Dementia in Ontario: A Quantitative Assessment of the Problem
Robert W Hopkins, Lindy Kilik, Duncan JA Day, Catherine Rows, Heidi Tseng

(PDF)

GABAergic Function in Alzheimer’s Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia
Krista L Lanctôt, Nathan Herrmann, Paolo Mazzotta, Lyla R Khan, Neil Ingber

(PDF)

Surrogate Decision-Making: Special Issues in Geriatric Psychiatry
Carole A Cohen

(PDF)

Defining Best Practices for Specialty Geriatric Mental Health Outreach Services: Lessons for Implementing Mental Health Reform
Mary Pat Sullivan, Linda Kessler, J Kenneth Le Clair, Paul Stolee, Whitney Berta

(PDF)


Review Paper
Preventing Postpartum Depression Part I: A Review of Biological Interventions

Cindy-Lee E Dennis

(PDF)


Original Research
Suicidal Ideation in Inpatients With Acute Schizophrenia

Vassilis Kontaxakis, Beata Havaki-Kontaxaki, Maria Margariti, Sophia Stamouli, Costas Kollias, George Christodoulou

(PDF)

The RCPSC Oral Examination: Patient Perceptions and Impact on Participating Psychiatric Patients
Philip Tibbo, Kelly Templeman

(PDF)


Brief Communication
Symptoms Defined by Parents’ and Teachers’ Ratings in Attention-Deficit Hyperactivity Disorder: Changes With Age

Bedriye Öncü, Özgür Öner, P1nar Öner, NeÕe Erol, Ayla Aysev, Saynur Canat

(PDF)


Book Reviews
(PDF)

The Therapist’s Notebook for Families: Solution-Oriented Exercises for Working With Parents, Children, and Adolescents
Review by
Lance Taylor, Karl Tomm


Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services
Review by
George Voineskos


Dementia: Presentations, Differential Diagnosis, and Nosology. 2nd ed.
Review by
Matthew Robillard


Letters to the Editor
(PDF)

Mirtazapine-Induced Shopping Spree

Age at Onset of Bipolar II Disorder

Venlafaxine-Associated Hypomania in Unipolar Depression

Hypnopompic Hallucinations During Olanzapine Treatment

Atypical Neuroleptic Malignant Syndrome Caused by Clozapine and Venlafaxine: Early Brief Treatment With Dantrolene

A Case of de Clérambault Syndrome in a Male Stalker With Paranoid Schizophrenia

Calcitonin Treatment for Phantom Limb Pain

The Use of Atomoxetine Adjunctively in Fibromyalgia Syndrome
Re: Autism—Its Detection, Causes, and Treatment


Letters to the Editor

Mirtazapine-Induced Shopping Spree

Dear Editor:

Many antidepressants, either alone or in combination, can induce mania. Mirtazapine is a new noradrenergic and specific serotinergic antidepressant that has been associated with mania when used to augment fluoxetine (1) and with hypomania when combined with sertraline (2). Bhanji and others have recently proposed a “norepinephrine syndrome” of dysphoric mania that is based on mirtazapine’s mechanism of action and a constellation of symptoms it likely caused when prescribed at high dosages (3). We report the case of a young woman who went on a shopping spree after mirtazapine was added to paroxetine that was unsuccessful in treating her depression.

Case Report

The patient is a mother of 3, aged 35 years, with a positive family history of unipolar depression. Seven years earlier, she had been diagnosed with postpartum depression that was successfully treated with paroxetine. After stopping the paroxetine, she remained well until recently, when she presented to her family physician with complaints of fatigue, decreased libido, loss of interest, bouts of tearfulness, and panic attacks. Her doctor started her on paroxetine 10 mg daily and subsequently referred her to the local psychiatrist, who confirmed the diagnosis of a major depressive illness and increased her paroxetine gradually to 50 mg daily. Despite the above regimen, she continued to suffer from depression, except for rare good days when she was able to do some of her housework. To relieve the depression, bupropion, olanzapine, and L-tryptophan were separately added to the paroxetine, but with little success.

After stopping the above 3 agents because they failed to boost the antidepressant effect of paroxetine, her psychiatrist added mirtazapine to her treatment. The dosage was gradually increased to 45 mg daily, and she took the combination for 8 weeks. Around this time, the patient was referred to the Mood Disorder Service for consultation. She reported that she had become irritable and impulsive. She described herself as easily “snapping” at people. Her energy had increased and she had started binge eating for the first time. Most dramatically, she began to make large purchases; for example, she bought 10 T-shirts and 5 pairs of shorts for her children, 5 pairs of pants and 8 pairs of shorts for herself, and magnifying glasses for many of the neighbourhood children. Her husband had to return all these items.

Mirtazapine-induced hypomania was recognized, the mirtazapine was discontinued, and the shopping sprees ceased soon thereafter. The remaining hypomanic symptoms also subsided later. However, the patient experienced depression. Her mood has stabilized with the addition of lithium carbonate.

Conclusion

The sudden episode of excessive and inappropriate spending resolved promptly when the offending agent, mirtazapine, was discontinued. We believe this is the first case of a shopping spree that was precipitated by the addition of mirtazapine to paroxetine when the latter failed to treat depressive symptoms.

References

1. Ng B. Mania associated with mirtazapine augmentation of fluoxetine. Depress Anxiety 2002;15:46–7.

2. Soutullo CA, McElroy SL, Keck PE. Hypomania associated with mirtazapine augmentation of sertraline. J Clin Psychiatry 1998;59:320.

3. Bhanji NH, Margolese HC, Saint-Laurent M, Chouinard G. Dysphoric mania induced by high dose mirtazapine: a case for “norepinephrine syndrome.” Int Clin Psychopharmacol 2002;17:319–22.

Eric Prost, MD
Gaby Abraham, MD, FRCPC
Kingston, Ontario




CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2001 | Index RCP des auteurs 2001
Author Index to 2002 | Index RCP des auteurs 2002
Author Index to 2003 | Index RCP des auteurs 2003
Subject Index to 2001 | Index RCP des sujets 2001
Subject Index to 2002 | Index RCP des sujets 2002
Subject Index to 2003 | Index RCP des sujets 2003
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil